BP (BP) Stock Drops Despite Market Gains: Important Facts to Note

BP (BP) stock recently dropped 1.27% to $34.12, significantly underperforming the broader market and its sector over the past month. Ahead of its Q3 2025 earnings release on November 4, analysts forecast a 10.84% year-over-year EPS decline to $0.74, despite a projected 30.97% revenue increase to $63.3 billion, highlighting a potential margin squeeze. The company currently holds a Zacks Rank #3 (Hold) and trades at a Forward P/E of 12.88, a premium to its industry's 10.83 average, while its PEG ratio of 1.78 is in line with the industry.

Analysis

BP's recent stock performance indicates significant headwinds, with a 1.27% drop to $34.12 during a positive market session and a one-month gain of 1.5% that trails both its Oils-Energy sector (+3.95%) and the S&P 500 (+2.99%). The critical focus is the conflicting forward-looking consensus estimates for its upcoming earnings. While revenue is projected to surge 30.97% year-over-year to $63.3 billion, a simultaneous 10.84% decline in EPS to $0.74 is anticipated, pointing towards substantial margin compression. This theme of profitability erosion extends to the full-year forecast, which calls for a 17.79% decrease in EPS despite a 13.79% revenue increase. In a slightly offsetting signal, the consensus EPS estimate has risen 1.73% in the past month, reflecting some short-term analyst optimism and supporting a neutral Zacks Rank #3 (Hold). From a valuation standpoint, BP trades at a Forward P/E of 12.88, representing a premium to its industry's average of 10.83, while its PEG ratio of 1.78 is in line with the industry average, suggesting the market is pricing in growth that may be challenged by the negative earnings outlook.

Key Decisions for Investors

• Investors should closely monitor the upcoming November 4 earnings release for management's explanation of the severe margin compression implied by forecasts of surging revenue and declining EPS.
• The stock's valuation premium, with a Forward P/E of 12.88 versus the industry's 10.83, warrants caution given its recent market underperformance and the negative full-year earnings growth forecast of -17.79%.
• A neutral stance is advisable; while the Zacks #3 (Hold) rating and recent upward EPS estimate revisions suggest holding existing positions, the significant negative catalysts make initiating new long positions appear risky ahead of further clarification on profitability.